Risk factors for pulmonary arterial hypertension

被引：84

作者：

Humbert, M ^{[1
]}

Nunes, H ^{[1
]}

Sitbon, O ^{[1
]}

Parent, F ^{[1
]}

Hervé, P ^{[1
]}

Simonneau, G ^{[1
]}

机构：

[1] Univ Paris Sud, Ctr Maladies Vasc Pulm, Serv Pneumol & Reanimat Resp, Hop Antoine Beclere, F-92140 Clamart, France

来源：

CLINICS IN CHEST MEDICINE | 2001年 / 22卷 / 03期

关键词：

D O I：

10.1016/S0272-5231(05)70284-7

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Several risk factors for pulmonary arterial hypertension have been recognized including drugs and toxins, demographic and medical conditions, and diseases. Conclusions regarding the causal relationship between risk factors and the development of pulmonary hypertension relate to the magnitude of the association, the temporality of the association, and consistency of the observations. The exact mechanism(s) by which the risk factors produce pulmonary hypertension has not been established yet. Given the fact that the absolute risk is generally low, factors of individual susceptibility are likely to play an important role.

引用

页码：459 / +

页数：19

共 127 条

[81] Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32 [J].

Nichols, WC ;

Koller, DL ;

Slovis, B ;

Foroud, T ;

Terry, VH ;

Arnold, ND ;

Siemieniak, DR ;

Wheeler, L ;

Phillips, JA ;

Newman, JH ;

Conneally, PM ;

Ginsburg, D ;

Loyd, JE .

NATURE GENETICS, 1997, 15 (03) :277-280

[82]

NUNES H, 1998, SANG THROMBOSE VAISS, V10, P555

[83] HIV-associated primary pulmonary hypertension - A case control study [J].

Opravil, M ;

Pechere, M ;

Speich, R ;

JollerJemelka, HI ;

Jenni, R ;

Russi, EW ;

Hirschel, B ;

Luthy, R ;

Battegay, M ;

Burgisser, P ;

Doorly, R ;

Egger, M ;

Erb, P ;

Fierz, W ;

Flepp, M ;

Francioli, P ;

Grob, P ;

Gruninger, U ;

Hirschel, B ;

Ledergerber, B ;

Luthy, R ;

Malinverni, R ;

Matter, L ;

Opravil, M ;

Paccaud, F ;

Perrin, L ;

Pichler, W ;

Rickenbach, M ;

Rutschmann, O ;

Vernazza, P ;

vonOverbeck, J .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (03) :990-995

[84] PULMONARY-HYPERTENSION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - COMPARISON WITH PRIMARY PULMONARY-HYPERTENSION [J].

PETITPRETZ, P ;

BRENOT, F ;

AZARIAN, R ;

PARENT, F ;

RAIN, B ;

HERVE, P ;

SIMONNEAU, G .

CIRCULATION, 1994, 89 (06) :2722-2727

[85]

Petureau F, 1998, REV MAL RESPIR, V15, P97

[86]

PHILEN RM, 1993, MAYO CLIN PROC, V68, P823, DOI 10.1016/S0025-6196(12)60646-6

[87] TYPE-I GLYCOGEN-STORAGE DISEASE WITH FOCAL NODULAR HYPERPLASIA OF THE LIVER AND VASOCONSTRICTIVE PULMONARY-HYPERTENSION [J].

PIZZO, CJ .

PEDIATRICS, 1980, 65 (02) :341-343

[88] PULMONARY-HYPERTENSION AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - 2 REPORTS AND A REVIEW OF THE LITERATURE [J].

POLOS, PG ;

WOLFE, D ;

HARLEY, RA ;

STRANGE, C ;

SAHN, SA .

CHEST, 1992, 101 (02) :474-478

[89] AGE AND SEX INFLUENCE ON PULMONARY-HYPERTENSION OF CHRONIC HYPOXIA AND ON RECOVERY [J].

RABINOVITCH, M ;

GAMBLE, WJ ;

MIETTINEN, OS ;

REID, L .

AMERICAN JOURNAL OF PHYSIOLOGY, 1981, 240 (01) :H62-H72

[90] Anorexigens and pulmonary hypertension in the United States - Results from the surveillance of North American pulmonary hypertension [J].

Rich, S ;

Rubin, L ;

Walker, AM ;

Schneeweiss, S ;

Abenhaim, L .

CHEST, 2000, 117 (03) :870-874

← 4 5 6 7 8 9 10 11 12 13 →